Associated Papers
Development of a functional assay for the characterisation of SMAD4 variants from the French haemorrhagic hereditary telangiectasia cohort.
Despas L et al.
Journal of Medical Genetics, 2025
Innate immune dynamics in the context of multisite EGFR mutations in lung adenocarcinoma.
Peng Y et al.
Genes and Immunity, 2025
Differences in actionable genomic alterations between brain metastases and non‑brain metastases in patients with non‑small cell lung cancer.
Nian R et al.
International Journal of Oncology, 2022
35796015 (PubMed )
Supplement: Supplementary_Data6.xlsx › Sheet1
Human four-and-a-half LIM family members suppress tumor cell growth through a TGF-beta-like signaling pathway.
Ding L et al.
The Journal of Clinical Investigation, 2009
Regulation of large-scale chromatin unfolding by Smad4.
Yan J et al.
Biochemical and Biophysical Research Communications, 2004
Loss of Smad4 function in pancreatic tumors: C-terminal truncation leads to decreased stability.
Maurice D et al.
The Journal of Biological Chemistry, 2001
Formation of a stable heterodimer between Smad2 and Smad4.
Wu JW et al.
The Journal of Biological Chemistry, 2001
TGF-beta signaling and cancer: structural and functional consequences of mutations in Smads.
Hata A et al.
Molecular Medicine Today, 1998
Evaluation of the FHIT gene in colorectal cancers.
Thiagalingam S et al.
Cancer Research, 1996
Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers.
Thiagalingam S et al.
Nature Genetics, 1996
Select a paper to view details